An open source pharma roadmap

In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2017-04, Vol.14 (4), p.e1002276-e1002276
Hauptverfasser:	Balasegaram, Manica, Kolb, Peter, McKew, John, Menon, Jaykumar, Olliaro, Piero, Sablinski, Tomasz, Thomas, Zakir, Todd, Matthew H, Torreele, Els, Wilbanks, John
Format:	Artikel
Sprache:	eng
Schlagworte:	Abbreviations African trypanosomiasis Alzheimer's disease Analysis Antimicrobial resistance Artesunate Business law Cancer Clinical trials Commercialization Community participation Competition Competitive Behavior Computer and Information Sciences Consumer Advocacy - standards Data processing Drug development Drug discovery Drug Discovery - economics Drug Discovery - methods Drug Discovery - organization & administration Drug Industry - economics Drug Industry - methods Drug Industry - organization & administration Health risks Humans India Innovations Life sciences Malaria Medicine and Health Sciences Models, Theoretical Neurodegenerative diseases Nitroimidazole Open source software Organizations, Nonprofit Pharmaceutical industry Pharmaceutical Preparations - supply & distribution Product development Public health R&D Rectum Research & development Research - economics Research - organization & administration Reviews Risk assessment Science Policy Social Sciences Software Specialization Translation Tropical diseases Tuberculosis Visceral leishmaniasis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1002276